International Journal of Pharma and Bio Sciences
 
 
    ISSN 0975-6299
www.ijpbs.net


ORIGINAL RESEARCH ARTICLE
Int J Pharm Bio Sci Volume 14 Issue 1, January - March, Pages:1-8

Self-Medication Practices Among the General Public During COVID-19 Pandemic Era-A Cross- Sectional Study.

Sindhura Nagisetty, T. Tulasi Madhuri, J. Naga Sreenivasulu, K.P. Poojitha, B. Ramesh and P. Jagadeesh.
DOI: http://dx.doi.org/10.22376/ijpbs.2023.14.1.p1-8
Abstract:

The practice of self-medication in the general public reached to highest level during the COVID-19 pandemic. Hospital admissions are less during the third wave. Most of the COVID-19 patients took treatment from home during 3rd wave. This study aims to evaluate the self-medication methods and practices in the general public and its impact on society. This retrospective observational cross-sectional study and the sample size were taken as 350 based on a previous study. The general public was approached via digital and social platforms and was given a pretested and validated questionnaire. The questionnaire was designed and sent as Google Forms. The questions are being given regarding self-medication practices. The education status of about 91% of the participants is graduation and higher. Sources of information for 67% of participants were doctors, 13% were family and friends, and 9% were pharmacies. 44% of them took self-medication for the prevention of COVID-19, and the majority of these people preferred homeopathy medication. About 54.4% of people took self-medication in the past 6 months for cold, cough, and sore throat. About 55% of them took antihistamines and vitamins D and C to relieve symptoms. In addition, 22% of the participants took antibiotics like Azithromycin-500mg once daily and Amoxicillin and Clavulanic acid twice a day 650 mg for 5 days to relieve the symptoms. The availability of drugs at home was one of the significant reasons for following self-medication practice, according to 52% of them. 44% of them reported 100% improvement in their symptoms. However, about 15% of them experienced mild adverse effects, like diarrhea, nausea, and stomach pain, with their self-medications. Self-medication without proper guidance and knowledge regarding the medicines is not advisable. Irrational use of drugs, especially antibiotics, can lead to the development of antimicrobial resistance.

Keywords: Self-Medication, COVID-19, Pandemic, General Public, Antibiotics, Over-The-Counter Drugs.
Full HTML:
  1. Nasir M, Talha KA, Chowdhury AS, Zahan T, Perveen RA. Prevalence, pattern.
  2. World Health Organization. Guidelines for the regulatory assessment of medicinal products for use in self-medication. Geneva: World Health Organization; 2000.
  3. Eticha T, Mesfin K. Self-medication practices in Mekelle, Ethiopia. PLOS ONE. 2014 May 12;9(5):e97464. doi: 10.1371/journal.pone.0097464, PMID 24820769.
  4. Assaf AM, Haddadin RN, Akour AA. COVID-19: between past and present. Viral Immunol. 2021 Apr 1;34(3):145-57. doi: 10.1089/vim.2020.0102, PMID 33017280.
  5. Al-Woraf YM. Drug safety in Yemen. In: Al-Woraf Y, editor. Drug safety in developing countries: achievements and challenges. Chennai: Elsevier Inc; 2020. p. 391-405.
  6. Chauhan V, Galwankar S, Raina S, Krishnan V. Proctoring hydroxychloroquine consumption for health-care workers in India as per the revised national guidelines. J Emerg Trauma Shock. 2020;13(2):172-3. doi: 10.4103/JETS.JETS_75_20, PMID 33013102.
  7. US Food and Drug Administration [internet]. FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems.[updated and cited 2020 January 7]. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or.
  8. Johnson RM, Vinetz JM. Dexamethasone in the management of COVID-19. BMJ. 2020;370:m2648. doi: 10.1136/bmj.m2648, PMID 32620554.
  9. World Health Organization. Coronavirus disease (COVID-19) advice for the public: mythbusters.
  10. World Health Organization Guidelines for regulatory assessment of medicinal products for use inself medication: general Information. WHO Drug Inf. 2000;14:18-26.
  11. Hughes CM, McElnay JC, Fleming GF. Benefits and risks of self-medication. Drug Saf. 2001;24(14):1027-37. doi: 10.2165/00002018-200124140-00002, PMID 11735659.
  12. Azhar HA, Tauseef AM, Usman TA, Azhar YO, Ahmed MO, Umer KH et al. Prevalence, attitude and knowledge of self-medication during Covid-19 disease pandemic. Pak J Med Health Sci. 2021;15:902-5. doi: 10.53350/pjmhs21155902.
  13. Wegbom AI, Edet CK, Raimi O, Fagbamigbe AF, Kiri VA. Self-medication practices and associated factors in the prevention and/or treatment of COVID-19 virus: A population-based survey in Nigeria. Front Public Health. 2021;9:606801. doi: 10.3389/fpubh.2021.606801, PMID 34150693.
  14. Azhar HA, Tauseef AM, Usman TA, Azhar YO, Ahmed MO, Umer KH et al. Prevalence, attitude and knowledge of self-medication during Covid-19 disease pandemic. Pak J Med Health Sci. 2021;15:902-5. doi: 10.53350/pjmhs21155902.
  15. Elayeh E, Akour A, Haddadin RN. Prevalence and predictors of self?medication drugs to prevent or treat COVID?19: experience from a Middle Eastern country. Int J Clin Pract. 2021 Nov;75(11):e14860. doi: 10.1111/ijcp.14860, PMID 34516713.
  16. Phalke VD, Phalke DB, Durgawale PM. Self-medication practices in rural Maharashtra. Indian J Community Med. 2006 Jan 1;31(1):34. doi: 10.4103/0970-0218.54933.
  17. Ahmad A, Patel I, Mohanta GP, Balkrishnan R. Evaluation of self-medication practices in a rural area of town Sahaswan at Northern India. Ann Med Health Sci Res. 2014;4(Suppl 2):S73-8. doi: 10.4103/2141-9248.138012, PMID 25184092.
  18. Mutua CM, Muthuka JK, Muthoka MN, Wambura FM. Pattern and Practices of Self-Medication during COVID-19 Pandemic in Urban Settings, Kenya: ”DoesCOVID-19 pandemic have a marginal Influence?”
  19. Pagán JA, Ross S, Yau J, Polsky D. Self-medication and health insurance coverage in Mexico. Health Policy. 2006;75(2):170-7. doi: 10.1016/j.healthpol.2005.03.007, PMID 16338480.
  20. Wabe N, Ahmed D, Angamo M. Self-medication with antibiotics and antimalarials in the community of site zone, South Ethiopia. TAF Prev Med Bull. 2012;11(5). doi: 10.5455/pmb.1-1314892446.
  21. Verma RK, Mohan L, Pandey M. Evaluation of self-medication among professional students in North India: proper statutory drug control must be implemented. Asian J Pharm Clin Res. 2010;3(1).
  22. Roy D, Tripathy S, Kar SK, Sharma N, Verma SK, Kaushal V. Study of knowledge, attitude, anxiety & perceived mental healthcare need in Indian population during COVID-19 pandemic. Asian J Psychiatr. 2020;51:102083. doi: 10.1016/j.ajp.2020.102083, PMID 32283510.
  23. Bolton J, Cox B, Clara I, Sareen J. Use of alcohol and drugs to self-medicate anxiety disorders in a nationally representative sample. J NervMent Dis. 2006;194(11):818-25. doi: 10.1097/01.nmd.0000244481.63148.98, PMID 17102705.
  24. Chopra D, Bhandari B, Sidhu JK, Jakhar K, Jamil F, Gupta R. Prevalence of self-reported anxiety and self-medication among upper and middle socioeconomic strata amidst COVID-19 pandemic. J Educ Health Promot. 2021;10:73. doi: 10.4103/jehp.jehp_864_20, PMID 34084820.
  25. Gama ASM, Secoli SR. Self-medication among nursing students in the state of Amazonas–Brazil. Rev GauchaEnferm. 2017 May 18;38(1):e65111. doi: 10.1590/1983-1447.2017.01.65111, PMID 28538809.
  26. Zardosht M, Dastoorpoor M, Hashemi FB, Estebsari F, Jamshidi E, Abbasi-Ghahramanloo A et al. Prevalence and causes of self-medication among medical students of Kerman University of Medical Sciences, Kerman, Iran. Glob J Health Sci. 2016 Mar 23;8(11):150-9. doi: 10.5539/gjhs.v8n11p150.
  27. Carter GT, Duong V, Ho S, Ngo KC, Greer CL, Weeks DL. Side effects of commonly prescribed analgesic medications. Phys Med Rehabil Clin N Am. 2014 May 1;25(2):457-70. doi: 10.1016/j.pmr.2014.01.007, PMID 24787343.
  28. Cunha BA. Antibiotic side effects. Med Clin North Am. 2001 Jan 1;85(1):149-85. doi: 10.1016/s0025-7125(05)70309-6, PMID 11190350.
[Download PDF]
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy
Pharmaceutical Fields
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmaceutics
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Novel drug delivery system
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Nanotechnology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacognosy
© Copyright 2009-2015 IJPBS, India. All rights reserved. Specialized online journals by ubijournal. Website by Ubitech Solutions
         Home I Contact I Terms & Conditions